2-HOBA supplement study for high lipoprotein(a)
Part of Hormones & metabolism clinical trials.
This trial tests whether a dietary supplement called 2-HOBA can help people with high levels of lipoprotein(a), a type of fat in the blood linked to heart disease. You take the supplement daily for several weeks while following your doctor's diet advice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 69 years old.
- You have high lipoprotein(a) levels (90 mg/dL or more).
- You are willing to follow a doctor-recommended diet during the study.
- You are not pregnant, planning pregnancy, or breastfeeding.
- You do not have known heart disease, bleeding disorders, or serious liver, kidney, or thyroid problems.
- You have not had major weight changes, donated blood recently, or used alcohol or drugs heavily in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
This study tests if a medication called olpasiran can lower a type of fat in your blood called Lp(a), which is linked to heart problems. You take the medicine or a placebo and get a special heart scan to see changes in your arteries.
This Phase 2 trial tests whether 2-HOBA can improve how “good cholesterol” (HDL) works in people with familial hypercholesterolemia (FH). If HDL works better, it may help lower heart risk markers. You would need to meet several heart, health, and medication-related safety checks.
This trial tests whether a natural compound called 2-HOBA can help women with lupus who also have mildly high blood pressure. It aims to improve blood vessel health and reduce inflammation.
This study tests an oral medicine (HRS-5346) to lower lipoprotein(a), a type of fat in the blood linked to heart problems. It might help people with high levels who are at increased risk for heart attacks or strokes.
This trial tests an experimental drug called 2-HOBA in people with pulmonary arterial hypertension (PAH). The goal is to see if it can help improve symptoms and slow disease progression.
Hear when a new Hyperlipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.